NEW YORK (GenomeWeb News) – Fluorotechnics said today that it has raised nearly AUS$8 million (US$4.95 million) through an initial public offering on the Australian Stock Exchange.
 
The Sydney-based firm said the offering was supported by institutional investors from Asia, Australia, and Europe, in addition to professional and retail investors.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.